Yatin Dholakia

538 total citations
27 papers, 356 citations indexed

About

Yatin Dholakia is a scholar working on Infectious Diseases, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Yatin Dholakia has authored 27 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 14 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yatin Dholakia's work include Tuberculosis Research and Epidemiology (21 papers), Pneumonia and Respiratory Infections (6 papers) and Vitamin D Research Studies (5 papers). Yatin Dholakia is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Pneumonia and Respiratory Infections (6 papers) and Vitamin D Research Studies (5 papers). Yatin Dholakia collaborates with scholars based in India, United States and Canada. Yatin Dholakia's co-authors include Nerges Mistry, Sheela Rangan, Shimoni Shah, Eunice Lobo, Sven Hoffner, Mark P. Nicol, Geoffrey Pasvol, Robert J. Wilkinson, M Uplekar and Herbert L. DuPont and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMC Public Health.

In The Last Decade

Yatin Dholakia

23 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yatin Dholakia India 11 285 215 58 47 33 27 356
Ramya Ananthakrishnan India 11 262 0.9× 171 0.8× 51 0.9× 70 1.5× 41 1.2× 24 305
A. Sreenivas India 10 334 1.2× 238 1.1× 58 1.0× 19 0.4× 30 0.9× 17 440
Agnes Gebhard Netherlands 10 322 1.1× 231 1.1× 125 2.2× 34 0.7× 35 1.1× 20 377
Nimalan Arinaminpathy United Kingdom 10 277 1.0× 171 0.8× 45 0.8× 39 0.8× 30 0.9× 23 376
Phanindra Dewan India 12 336 1.2× 268 1.2× 89 1.5× 57 1.2× 43 1.3× 18 403
Joseph Sitienei Kenya 14 331 1.2× 240 1.1× 78 1.3× 44 0.9× 59 1.8× 25 413
Devesh Gupta India 10 251 0.9× 158 0.7× 99 1.7× 32 0.7× 26 0.8× 23 301
Mao Tan Eang Cambodia 12 368 1.3× 271 1.3× 83 1.4× 67 1.4× 95 2.9× 24 469
Hannah Alsdurf Canada 7 412 1.4× 331 1.5× 135 2.3× 26 0.6× 40 1.2× 15 491
D. F. Wares India 15 448 1.6× 339 1.6× 125 2.2× 23 0.5× 41 1.2× 27 541

Countries citing papers authored by Yatin Dholakia

Since Specialization
Citations

This map shows the geographic impact of Yatin Dholakia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yatin Dholakia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yatin Dholakia more than expected).

Fields of papers citing papers by Yatin Dholakia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yatin Dholakia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yatin Dholakia. The network helps show where Yatin Dholakia may publish in the future.

Co-authorship network of co-authors of Yatin Dholakia

This figure shows the co-authorship network connecting the top 25 collaborators of Yatin Dholakia. A scholar is included among the top collaborators of Yatin Dholakia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yatin Dholakia. Yatin Dholakia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Kamal Kant, Yogesh N. Marathe, Molin Wang, et al.. (2023). Vitamin D and Zinc Supplementation to Improve Treatment Outcomes among COVID-19 Patients in India: Results from a Double-Blind Randomized Placebo-Controlled Trial. Current Developments in Nutrition. 7(8). 101971–101971. 2 indexed citations
2.
Sharma, Kamal Kant, Yogesh N. Marathe, Molin Wang, et al.. (2023). P12-017-23 Effect of Vitamin D and Zinc Supplementation on Treatment Outcomes Among COVID-19 Patients in India: Results From a Double-Blind Randomized Placebo-Controlled Trial. Current Developments in Nutrition. 7. 100441–100441.
3.
Sharma, Kamal Kant, Nerges Mistry, Yogesh N. Marathe, et al.. (2022). Randomised trial to determine the effect of vitamin D and zinc supplementation for improving treatment outcomes among patients with COVID-19 in India: trial protocol. BMJ Open. 12(8). e061301–e061301. 6 indexed citations
4.
Dholakia, Yatin. (2022). Pulmonary Non-tuberculous Mycobacterial Infections in Category II Failures from National Tuberculosis Programme. The Indian Journal of Chest Diseases and Allied Sciences. 57(1). 27–30.
5.
Dholakia, Yatin. (2022). Innovative approach to delivery of TB Medicines. Lung India. 40(1). 68–69.
6.
Mistry, Nerges, Elena C. Hemler, Yatin Dholakia, et al.. (2020). Protocol for a case–control study of vitamin D status, adult multidrug-resistant tuberculosis disease and tuberculosis infection in Mumbai, India. BMJ Open. 10(11). e039935–e039935. 4 indexed citations
7.
Rangan, Sheela, et al.. (2019). Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us. PLoS ONE. 14(1). e0209924–e0209924. 17 indexed citations
8.
Mistry, Nerges, Eunice Lobo, Shimoni Shah, Sheela Rangan, & Yatin Dholakia. (2017). Pulmonary tuberculosis in Patna, India: Durations, delays, and health care seeking behaviour among patients identified through household surveys. Journal of Epidemiology and Global Health. 7(4). 241–241. 34 indexed citations
9.
Dholakia, Yatin & Nerges Mistry. (2016). Tuberculosis in congregate settings: Policies and practices in various facilities in Mumbai, India. Indian Journal of Tuberculosis. 64(1). 10–13.
10.
Mistry, Nerges, et al.. (2016). Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India. PLoS ONE. 11(3). e0152287–e0152287. 72 indexed citations
11.
Dholakia, Yatin, et al.. (2015). Profile of NGOs involved in management of MDR TB in Mumbai before rollout of DOTS Plus. Indian Journal of Tuberculosis. 62(2). 124–127. 2 indexed citations
12.
Mistry, Nerges, et al.. (2015). New drugs for tuberculosis. Drugs of the Future. 40(1). 39–39. 2 indexed citations
13.
Dholakia, Yatin, Quazi Syed Zahiruddin, & Nerges Mistry. (2012). Drug-resistant tuberculosis: Study of clinical practices of chest physicians, Maharashtra, India. Lung India. 29(1). 30–30. 6 indexed citations
14.
Dholakia, Yatin, et al.. (2012). Chest X-rays and associated clinical parameters in pulmonary Tubercolosis cases from the National Tubercolosis Program, Mumbai, India. Infectious Disease Reports. 4(1). e10–e10. 10 indexed citations
16.
Thakur, Harshad, et al.. (2008). National workshop on public private participation (PPP) for TB control in India--a brief review.. PubMed. 55(4). 224–6. 1 indexed citations
17.
Mistry, Nerges, et al.. (2006). Rhodococcus and Mycobacterium Tuberculosis: masquerade or mixed infection.. PubMed. 10(3). 351–3. 10 indexed citations
18.
Lönnroth, Knut, et al.. (2005). Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India.. PubMed. 9(5). 562–8. 38 indexed citations
19.
Sheikh, Kabir, et al.. (2005). Urban private practitioners: potential partners in the care of patients with HIV/AIDS.. PubMed. 18(1). 32–6. 13 indexed citations
20.
Dholakia, Yatin, et al.. (2000). Relapse following directly observed therapy short course (DOTS) - a follow up study.. Indian Journal of Tuberculosis. 47(4). 233–236. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026